Application Nr Approved Date Route Status External Links
NDA021172 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Novolog Mix 70/30 Is A Mixture Of Insulin Aspart Protamine And Insulin Aspart Indicated To Improve Glycemic Control In Patients With Diabetes Mellitus. Limitations Of Use: Novolog Mix 70/30 Is Not Recommended For The Treatment Of Diabetic Ketoacidosis. The Proportions Of Rapid-Acting And Long-Acting Insulins In Novolog Mix 70/30 Are Fixed And Do Not Allow For Basal Versus Prandial Dose Adjustments. Novolog Mix 70/30 Is A Mixture Of Insulin Aspart Protamine, An Intermediate-Acting Human Insulin Analog, And Insulin Aspart, A Rapid-Acting Human Insulin Analog, Indicated To Improve Glycemic Control In Patients With Diabetes Mellitus. Limitations Of Use: Not Recommended For The Treatment Of Diabetic Ketoacidosis. The Proportions Of Rapid-Acting And Long-Acting Insulins Are Fixed And Do Not Allow For Basal Versus Prandial Dose Adjustments (1) .

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Insulin Aspart

Comments